Legal & General Group
BIOA

Legal & General Group’s BioAge Labs BIOA Stock Holding History

Legal & General Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.4K Buy
2,655
+503
+23% +$9.69K ﹤0.01% 2690
2025
Q4 		$28.5K Hold
2,152
– – ﹤0.01% 2891
2025
Q3 		$12.7K Hold
2,152
– – ﹤0.01% 3225
2025
Q2 		$8.89K Buy
2,152
+832
+63% +$3.35K ﹤0.01% 3321
2025
Q1 		$4.96K Hold
1,320
– – ﹤0.01% 3280
2024
Q4 		$7.69K Buy
+1,320
New +$22.8K ﹤0.01% 3298

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Legal & General Group's BIOA Position: Q1 2026 in Review

Legal & General Group increased its BioAge Labs (BIOA) stake by 23% in Q1 2026, buying an estimated $9.69K and bringing the position to 2,655 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2690.

Legal & General Group first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Legal & General Group held 2,655 shares of BioAge Labs worth $46.4K as of Q1 2026.
  • Legal & General Group bought 503 BioAge Labs shares in Q1 2026, an estimated $9.69K.
  • BioAge Labs made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2690 holding.
  • Legal & General Group first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.